McAlvany Wealth Management LLC grew its holdings in Global X 1-3 Month T-Bill ETF (NYSEARCA:CLIP – Free Report) by 94.9% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 18,472 shares of the company’s stock after buying an additional 8,994 shares during the quarter. McAlvany Wealth Management LLC owned about 0.08% of Global X 1-3 Month T-Bill ETF worth $1,853,000 at the end of the most recent quarter.
A number of other institutional investors have also recently modified their holdings of the business. Latitude Advisors LLC acquired a new position in Global X 1-3 Month T-Bill ETF during the third quarter worth $59,000. Creekmur Asset Management LLC purchased a new position in Global X 1-3 Month T-Bill ETF in the second quarter worth $118,000. Geneos Wealth Management Inc. purchased a new position in Global X 1-3 Month T-Bill ETF in the first quarter worth $146,000. MADDEN SECURITIES Corp purchased a new position in Global X 1-3 Month T-Bill ETF in the third quarter worth $151,000. Finally, IFP Advisors Inc lifted its holdings in Global X 1-3 Month T-Bill ETF by 29.8% in the second quarter. IFP Advisors Inc now owns 1,948 shares of the company’s stock valued at $195,000 after acquiring an additional 447 shares during the period.
Global X 1-3 Month T-Bill ETF Price Performance
Global X 1-3 Month T-Bill ETF stock opened at $100.08 on Tuesday. Global X 1-3 Month T-Bill ETF has a one year low of $100.04 and a one year high of $100.41. The business has a fifty day moving average of $100.22 and a two-hundred day moving average of $100.22.
About Global X 1-3 Month T-Bill ETF
The Global X 1-3 Month T-Bill ETF (CLIP) is an exchange-traded fund that is based on the Solactive 1-3 month US T-Bill – USD index. The fund tracks a market value-weighted index of USD-denominated, zero-coupon US Treasury bills with a time to maturity of one to three months. CLIP was launched on Jun 20, 2023 and is managed by Global X.
Recommended Stories
- Five stocks we like better than Global X 1-3 Month T-Bill ETF
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AI—These 5 Stocks Are Getting Paid
Receive News & Ratings for Global X 1-3 Month T-Bill ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global X 1-3 Month T-Bill ETF and related companies with MarketBeat.com's FREE daily email newsletter.
